Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation

Thursday, October 23, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster titled 'Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation' was presented at ESMO 2025. It highlights the use of epigenetic nucleosomes as a promising tool for differentiating pulmonary nodules, potentially enhancing diagnostic accuracy. The research is linked to the prognostic value of the Nu.Q® Cancer Test.
Price reaction · baseline $8.44 (2025-10-22 close) · hit pre-market · clean, no other VNRX news in the window
day 0 close · peak
+0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a notable conference (ESMO 2025).
  • Focus on innovative epigenetic nucleosomes for cancer differentiation.
  • Potential for improved diagnostic methods in pulmonary nodules.

Full Press Release Details

Poster titled: Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
Pei-Hsing Chen, Tai-Horng Young, T.-P. Lu, D. Pamart, A. Kotronoulas, M. Herzog, J. Micallef, Hsao-Hsun Hsu, Jin-Shing Chen
Presented at ESMO 2025

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at ESMO 2025?

The poster titled 'Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation' was presented.

What is the focus of the research?

The research focuses on using epigenetic nucleosomes to differentiate pulmonary nodules.

What is the significance of the Nu.Q® Cancer Test?

The Nu.Q® Cancer Test is linked to the prognostic value of the research findings.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare pulmonary nodules cancer diagnostics ESMO 2025 Nu.Q Cancer Test
Last updated: Oct 23, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk